Results 181 to 190 of about 109,824 (227)

Development of a Novel Drug Delivery System "Nanoemulfoam" for Topical Delivery of Terbinafine Hydrochloride as a Repurposed Therapy in Skin Cancer: Formulation, Optimization, In Vitro Characterization, Ex Vivo Transdermal Permeability, Cytotoxicity Studies, and In Silico Assessment. [PDF]

Pharmaceuticals (Basel)
Musallam AA, Aldeeb RA, Mansour RM, Kassem MAE, Saeed DF, Mahdy MA, Abdelnaby RM, Elnahas HM, Ibrahim TM.   +8 more
europepmc   +1 more source

Aberrant strand transfer events across multiple stages of reverse transcription shape the heterogeneous landscape of the HIV-1 reservoir. [PDF]

Commun Biol
Hardy J, Mortier V, De Meersman Y, Staelens D, Demecheleer E, Schauvliege M, Vermeersch C, Padalko E, Verhofstede C.   +8 more
europepmc   +1 more source

HIV-2 glycoproteins upregulate microRNAs 25 and 93 to counter the MARCH1 antiviral effect in macrophages. [PDF]

J Virol
Lodge R, Kmiec D, Kirchhoff F, Cohen ÉA.   +3 more
europepmc   +1 more source

Mechanisms of Immune Evasion in HIV-1: The Role of Virus-Host Protein Interactions. [PDF]

Curr Issues Mol Biol
Mouzakis A, Petrakis V, Tryfonopoulou E, Panopoulou M, Panagopoulos P, Chlichlia K.   +5 more
europepmc   +1 more source

Lithium attenuates HIV-1 latency reversal in an autophagy-independent way. [PDF]

iScience
Abdalla AL, Guajardo-Contreras G, Chau BA, Niu M, Murooka T, Mouland AJ.   +5 more
europepmc   +1 more source

HIV Nef disrupts Lck signaling by inducing aberrant phosphorylation of its substrates. [PDF]

Immunohorizons
Guertin J, Chrobak P, Meunier C, Thomson CM, Hanna Z, Jolicoeur P.   +5 more
europepmc   +1 more source

Hsp110 nucleotide exchange factors may amplify Hsp70-disaggregation by enhanced entropic pulling. [PDF]

J Biol Chem
Rebeaud ME, Fauvet B, De Los Rios P, Goloubinoff P.   +3 more
europepmc   +1 more source

Understanding the performance of HIV-1 viral vector vaccines: adenovirus and poxvirus case studies. [PDF]

Front Immunol
Manafi MM, Farzani T, Espinoza N, Ozonoff A, Sabeti PC.   +4 more
europepmc   +1 more source

Synergistic latency reversal by the SMAC mimetic AZD5582 and iBET JQ1, combined with Nef ablation, facilitates immune-mediated elimination of latently HIV-1-infected T-cells

Postmus D, Hui C, Akbil B, Jansen J, Wooding D, Cingöz O, Goffinet C.   +6 more
europepmc   +1 more source

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study. [PDF]

Nat Commun
Sohai DK, Keller MD, Hanley PJ, Hoq F, Kukadiya D, Datar A, Reynolds E, Copertino DC, Lazarski C, McCann CD, Tanna J, Shibli A, Lang H, Zhang A, Chansky PA, Motta C, Huynh TT, Dwyer B, Wilson A, Lynch R, Mota TM, Conce Alberto WD, Brumme ZL, Kinloch NN, Cruz CRY, MacLaren Ehui L, Henn S, Brad Jones R, Bollard CM.   +28 more
europepmc   +1 more source